BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20334419)

  • 1. In-depth proteomic analyses of direct expressed prostatic secretions.
    Drake RR; Elschenbroich S; Lopez-Perez O; Kim Y; Ignatchenko V; Ignatchenko A; Nyalwidhe JO; Basu G; Wilkins CE; Gjurich B; Lance RS; Semmes OJ; Medin JA; Kislinger T
    J Proteome Res; 2010 May; 9(5):2109-16. PubMed ID: 20334419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.
    Principe S; Kim Y; Fontana S; Ignatchenko V; Nyalwidhe JO; Lance RS; Troyer DA; Alessandro R; Semmes OJ; Kislinger T; Drake RR; Medin JA
    J Proteome Res; 2012 Apr; 11(4):2386-96. PubMed ID: 22339264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.
    Kim Y; Ignatchenko V; Yao CQ; Kalatskaya I; Nyalwidhe JO; Lance RS; Gramolini AO; Troyer DA; Stein LD; Boutros PC; Medin JA; Semmes OJ; Drake RR; Kislinger T
    Mol Cell Proteomics; 2012 Dec; 11(12):1870-84. PubMed ID: 22986220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease.
    Drake RR; White KY; Fuller TW; Igwe E; Clements MA; Nyalwidhe JO; Given RW; Lance RS; Semmes OJ
    J Proteomics; 2009 Aug; 72(6):907-17. PubMed ID: 19457353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
    Principe S; Jones EE; Kim Y; Sinha A; Nyalwidhe JO; Brooks J; Semmes OJ; Troyer DA; Lance RS; Kislinger T; Drake RR
    Proteomics; 2013 May; 13(10-11):1667-1671. PubMed ID: 23533145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteomics of prostate cancer exosomes.
    Drake RR; Kislinger T
    Expert Rev Proteomics; 2014 Apr; 11(2):167-77. PubMed ID: 24564711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Proteome of Primary Prostate Cancer.
    Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
    Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
    Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
    Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
    Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
    Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
    Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic investigation of intra-tumor heterogeneity using network-based contextualization - A case study on prostate cancer.
    Goh WWB; Zhao Y; Sue AC; Guo T; Wong L
    J Proteomics; 2019 Aug; 206():103446. PubMed ID: 31323421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants.
    Nguyen EV; Centenera MM; Moldovan M; Das R; Irani S; Vincent AD; Chan H; Horvath LG; Lynn DJ; Daly RJ; Butler LM
    Mol Cell Proteomics; 2018 Aug; 17(8):1470-1486. PubMed ID: 29632047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard.
    Zhao T; Zeng X; Bateman NW; Sun M; Teng PN; Bigbee WL; Dhir R; Nelson JB; Conrads TP; Hood BL
    J Proteome Res; 2012 Feb; 11(2):1089-99. PubMed ID: 22077639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.
    Anklesaria JH; Mhatre DR; Mahale SD
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):535-562. PubMed ID: 28930560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
    Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
    Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of formalin-fixed prostate cancer tissue.
    Hood BL; Darfler MM; Guiel TG; Furusato B; Lucas DA; Ringeisen BR; Sesterhenn IA; Conrads TP; Veenstra TD; Krizman DB
    Mol Cell Proteomics; 2005 Nov; 4(11):1741-53. PubMed ID: 16091476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers.
    Lima T; Ferreira R; Freitas M; Henrique R; Vitorino R; Fardilha M
    J Proteome Res; 2022 Feb; 21(2):447-458. PubMed ID: 35114790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
    Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
    Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.
    Webber JP; Spary LK; Mason MD; Tabi Z; Brewis IA; Clayton A
    Oncotarget; 2016 Apr; 7(15):20124-39. PubMed ID: 26934553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.
    Meehan KL; Holland JW; Dawkins HJ
    Prostate; 2002 Jan; 50(1):54-63. PubMed ID: 11757036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.